DNA:NYSE
Ginkgo Bioworks Holdings Inc
၁၁.၃၄ US$
arrow_downward
-၁.၀၉%(-၀.၁၂) 1D
၁၂.၀၅ US$
arrow_upward
+၆.၂၆% (+၀.၇၁)todayPre-market
Closed: အောက် ၈, GMT-၄ ၁၆:၀၀:၀၃ · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for DNA...
Open
၁၀.၉၂ US$
High
၁၁.၄၁ US$
Low
၁၀.၆၁ US$
Mkt. cap
၇၂.၉၆ ကုဋေ
Avg. vol.
၂.၅၄ သန်း
Volume
၃.၃၂ သောင်း
52-wk high
၁၈.၂၂ US$
52-wk low
၅.၃၇ US$
EPS
-၅.၀၀ US$
Beta
၁.၇၉
Shares outstanding
၅.၅၄ ကုဋေ
No. of employees
၄၈၅
Open
၁၀.၉၂ US$
High
၁၁.၄၁ US$
Low
၁၀.၆၁ US$
Mkt. cap
၇၂.၉၆ ကုဋေ
Avg. vol.
၂.၅၄ သန်း
Volume
၃.၃၂ သောင်း
52-wk high
၁၈.၂၂ US$
52-wk low
၅.၃၇ US$
EPS
-၅.၀၀ US$
Beta
၁.၇၉
Shares outstanding
၅.၅၄ ကုဋေ
No. of employees
၄၈၅
News stories
From web sources and news partners
Investing.com
·
ပြီးခဲ့သည့် ၁၅ နာရီ
Ginkgo Bioworks to support NSF X-Labs with lab access
Investing.com
·
ပြီးခဲ့သည့် ၁ ရက်
Ginkgo Bioworks integrates Araceli imaging system into lab
Stock Titan
·
ပြီးခဲ့သည့် ၁ ရက်
An imaging system captures a plate of 1,536 tiny wells in under four minutes at Ginkgo's Boston lab.
Profile
Ginkgo Bioworks Holdings, Inc. is an American biotech company founded in 2008 by five scientists from MIT. The company specializes in using genetic engineering to produce bacteria with industrial applications for other biotech companies, saving other companies the cost of reproducing the initial stages of design in synthetic biology. The self-proclaimed "Organism Company" was one of the world's largest privately held biotech companies, valued at $4.2 billion in 2019. It raised $290 million in September and $350 million in October of that year. Ginkgo Bioworks went public on the New York Stock Exchange via a SPAC merger on September 17, 2021. Wikipedia
About Ginkgo Bioworks Holdings Inc
CEOJason Kelly
Employees၄၈၅
Founded၂၀၀၈
Headquartersဘော့စတွန်မြို့, မက်ဆာချူးဆက်ပြည်နယ်, ယူနိုက်တက်စတိတ်
Sector-
Websiteginkgo.bio